2024/08/30 22:26:26 | |
---|---|
Price | |
867.80 EUR | |
Difference | 2.18% (18.50) |
ISIN | US5324571083 |
Symbol | LLY |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 823,491 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 864.50 EUR (40) |
Ask (Ask size) | 869.20 EUR (40) |
Open | 848.10 EUR |
High | 868.90 EUR |
Low | 848.10 EUR |
Close (prev. day) | 849.30 EUR |
VWAP | 854.80858 EUR |
Volume (pcs) | 1,678 |
Trading volume | 1,434,368.80 |
Number of trades | 156 |
Last size | 57 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/08/12 |
![]() |
Global Equity Ratings |
![]() |
2024/07/24 |
![]() |
Global Equity Ratings |
![]() |
2024/07/12 |
![]() |
Global Equity Ratings |
![]() |
2024/06/21 |
![]() |
Global Equity Ratings |
![]() |
2024/06/14 |
![]() |
Global Equity Ratings |
![]() |
2024/08/30 22:26:26 | |
---|---|
Price | |
867.80 EUR | |
Difference | 2.18% (18.50) |
ISIN | US5324571083 |
Symbol | LLY |
Exchange | Tradegate |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 823,491 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | 864.50 EUR (40) |
Ask (Ask size) | 869.20 EUR (40) |
Open | 848.10 EUR |
High | 868.90 EUR |
Low | 848.10 EUR |
Close (prev. day) | 849.30 EUR |
VWAP | 854.80858 EUR |
Volume (pcs) | 1,678 |
Trading volume | 1,434,368.80 |
Number of trades | 156 |
Last size | 57 |
6m | 1Y | 3Y | |
Perf (%) | +24.53% | +72.91% | +290.46% |
Perf (abs.) | +171.00 | +366.00 | +645.70 |
Beta | 1.03 | 0.96 | 0.57 |
Volatility | 32.47 | 31.05 | 29.69 |
Ø price 5 days | Ø volume 5 days (pcs.) | 855.48 EUR (2,545) |
Ø price 30 days | Ø volume 30 days (pcs.) | 801.66 EUR (6,434) |
Ø price 100 days | Ø volume 100 days (pcs.) | 779.76 EUR (5,388) |
Ø price 250 days | Ø volume 250 days (pcs.) | 671.05 EUR (5,519) |
YTD High | date | 885.00 EUR (2024/07/15) |
YTD Low | date | 527.50 EUR (2024/01/02) |
52 Weeks High | date | 885.00 EUR (2024/07/15) |
52 Weeks Low | date | 488.00 EUR (2023/11/02) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Xetra | 2024/08/30 | 17:35 | 854.00 EUR | 1.92 | 253 |
Vienna Stock Exchange | 2024/08/30 | 17:32 | 852.40 EUR | 0.00 | 5 |
Tradegate | 2024/08/30 | 22:26 | 867.80 EUR | 1.43 | 156 |
Stuttgart | 2024/08/30 | 17:34 | 851.90 EUR | 0.04 | 10 |
SIX Swiss Exchange | 2024/08/19 | 09:06 | 800.00 CHF | 0.00 | 1 |
NYSE | 2024/08/30 | 22:02 | 960.02 USD | 2,436.23 | 77,137 |
Munich | 2024/08/30 | 08:04 | 851.30 EUR | 0.00 | 2 |
London Stock Exchange | 2021/12/10 | 15:37 | 225.3104 CHF | 0.02 | 1 |
Hanover | 2024/08/30 | 17:25 | 854.30 EUR | 0.00 | 4 |
Hamburg | 2024/08/30 | 19:25 | 854.70 EUR | 0.00 | 3 |
Frankfurt | 2024/08/30 | 21:39 | 864.20 EUR | 0.47 | 46 |
Euronext Milan MTF Trading After Hours | 2024/07/30 | 18:22 | 729.10 EUR | 0.00 | 1 |
Euronext Milan MTF Global Equity Market | 2024/08/30 | 17:44 | 854.30 EUR | 0.15 | 21 |
Duesseldorf | 2024/08/30 | 19:30 | 851.10 EUR | 0.00 | 7 |
Berlin | 2024/08/30 | 08:08 | 848.20 EUR | 0.00 | 3 |
ELI LILLY & CO. |
- - |
Lilly Corporate Center - 46285 Indianapolis |
Telefon: +1-317-276-2000 |
Fax: + |
E-mail: communications_corporate@lilly.com |
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN. |
Katherine Baicker | Member of Board of Directors |
Marschall Runge | Member of Board of Directors |
Mary Lynne Hedley | Member of Board of Directors |
William Kaelin | Member of Board of Directors |
Gabrielle Greene-Sulzberger | Member of Board of Directors |
Jamere Jackson | Member of Board of Directors |
Jon Fyrwald | Member of Board of Directors |
Juan Luciano | Member of Board of Directors |
Karen Walker | Member of Board of Directors |
Kimberly Johnson | Member of Board of Directors |
Ralph Alvarez | Member of Board of Directors |
David Ricks | Chairman of Managing Board |
Alonzo Weems | Member of Executive Committee |
Anat Ashkenazi | Member of Executive Committee |
Anat Hakim | Member of Executive Committee |
Anne E. White | Member of Executive Committee |
Daniel M. Skovronsky | Member of Executive Committee |
Diogo Rau | Member of Executive Committee |
Edgardo Hernandez | Member of Executive Committee |
Eric Dozier | Member of Executive Committee |
Ilya Yuffa | Member of Executive Committee |
Jacob Van Naarden | Member of Executive Committee |
Johna L. Norton | Member of Executive Committee |
Patrik Jonsson | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer